questionsmedicales.fr
Composés polycycliques
Composés macrocycliques
Lactames macrocycliques
Lactames macrocycliques : Questions médicales fréquentes
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Lactames macrocycliques : Questions médicales les plus fréquentes",
"headline": "Lactames macrocycliques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Lactames macrocycliques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-19",
"dateModified": "2025-04-15",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Lactames macrocycliques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Composés macrocycliques",
"url": "https://questionsmedicales.fr/mesh/D047028",
"about": {
"@type": "MedicalCondition",
"name": "Composés macrocycliques",
"code": {
"@type": "MedicalCode",
"code": "D047028",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.345"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Maitansine",
"alternateName": "Maytansine",
"url": "https://questionsmedicales.fr/mesh/D008453",
"about": {
"@type": "MedicalCondition",
"name": "Maitansine",
"code": {
"@type": "MedicalCode",
"code": "D008453",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.345.295.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Rifamycine",
"alternateName": "Rifamycins",
"url": "https://questionsmedicales.fr/mesh/D012294",
"about": {
"@type": "MedicalCondition",
"name": "Rifamycine",
"code": {
"@type": "MedicalCode",
"code": "D012294",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.345.295.750"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Rifabutine",
"alternateName": "Rifabutin",
"url": "https://questionsmedicales.fr/mesh/D017828",
"about": {
"@type": "MedicalCondition",
"name": "Rifabutine",
"code": {
"@type": "MedicalCode",
"code": "D017828",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.345.295.750.650"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Streptovarycine",
"alternateName": "Streptovaricin",
"url": "https://questionsmedicales.fr/mesh/D013310",
"about": {
"@type": "MedicalCondition",
"name": "Streptovarycine",
"code": {
"@type": "MedicalCode",
"code": "D013310",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.345.295.750.650.700"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Streptovarycine",
"alternateName": "Streptovaricin",
"url": "https://questionsmedicales.fr/mesh/D013310",
"about": {
"@type": "MedicalCondition",
"name": "Streptovarycine",
"code": {
"@type": "MedicalCode",
"code": "D013310",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.345.295.750.650.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Rifampicine",
"alternateName": "Rifampin",
"url": "https://questionsmedicales.fr/mesh/D012293",
"about": {
"@type": "MedicalCondition",
"name": "Rifampicine",
"code": {
"@type": "MedicalCode",
"code": "D012293",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.345.295.750.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Rifaximine",
"alternateName": "Rifaximin",
"url": "https://questionsmedicales.fr/mesh/D000078262",
"about": {
"@type": "MedicalCondition",
"name": "Rifaximine",
"code": {
"@type": "MedicalCode",
"code": "D000078262",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.345.295.750.850"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Lactames macrocycliques",
"alternateName": "Lactams, Macrocyclic",
"code": {
"@type": "MedicalCode",
"code": "D047029",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Jonathan L Sessler",
"url": "https://questionsmedicales.fr/author/Jonathan%20L%20Sessler",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, The University of Texas at Austin, Austin, Texas 78712-1224, United States."
}
},
{
"@type": "Person",
"name": "Chunju Li",
"url": "https://questionsmedicales.fr/author/Chunju%20Li",
"affiliation": {
"@type": "Organization",
"name": "College of Sciences, Center for Supramolecular Chemistry and Catalysis, Shanghai University, Shanghai, 200444, People's Republic of China. cjli@shu.edu.cn."
}
},
{
"@type": "Person",
"name": "Zhongzhen Yang",
"url": "https://questionsmedicales.fr/author/Zhongzhen%20Yang",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of York, Heslington York YO10 5DD UK William.unsworth@york.ac.uk."
}
},
{
"@type": "Person",
"name": "Adrian C Whitwood",
"url": "https://questionsmedicales.fr/author/Adrian%20C%20Whitwood",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of York, Heslington York YO10 5DD UK William.unsworth@york.ac.uk."
}
},
{
"@type": "Person",
"name": "William P Unsworth",
"url": "https://questionsmedicales.fr/author/William%20P%20Unsworth",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of York, Heslington York YO10 5DD UK William.unsworth@york.ac.uk."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Helicene-based π-conjugated macrocycles: their synthesis, properties, chirality and self-assembly into molecular stripes on a graphite surface.",
"datePublished": "2023-01-27",
"url": "https://questionsmedicales.fr/article/36383069",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1039/d2nr04209f"
}
},
{
"@type": "ScholarlyArticle",
"name": "Higher magnetic susceptibility of globus pallidus in patients after macrocyclic GBCAs: assessment using quantitative susceptibility mapping.",
"datePublished": "2022-12-26",
"url": "https://questionsmedicales.fr/article/36567675",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/02841851221147618"
}
},
{
"@type": "ScholarlyArticle",
"name": "High-Resolution Cryo-Electron Microscopy Reveals the Unique Striated Hollow Structure of Photocatalytic Macrocyclic Polydiacetylene Nanotubes.",
"datePublished": "2022-09-20",
"url": "https://questionsmedicales.fr/article/36126329",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/jacs.2c06710"
}
},
{
"@type": "ScholarlyArticle",
"name": "Grafting of the 2,8-dithia-5-aza-2,6-pyridinophane macrocycle on SBA-15 mesoporous silica for the removal of Cu",
"datePublished": "2022-08-16",
"url": "https://questionsmedicales.fr/article/35899774",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1039/d2dt01473d"
}
},
{
"@type": "ScholarlyArticle",
"name": "Landscaping macrocyclic peptides: stapling hDM2-binding peptides for helicity, protein affinity, proteolytic stability and cell uptake.",
"datePublished": "2022-05-31",
"url": "https://questionsmedicales.fr/article/35866171",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1039/d1cb00231g"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés polycycliques",
"item": "https://questionsmedicales.fr/mesh/D011083"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés macrocycliques",
"item": "https://questionsmedicales.fr/mesh/D047028"
},
{
"@type": "ListItem",
"position": 4,
"name": "Lactames macrocycliques",
"item": "https://questionsmedicales.fr/mesh/D047029"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Lactames macrocycliques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Lactames macrocycliques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Lactames macrocycliques",
"description": "Comment diagnostiquer une infection bactérienne ?\nQuels tests sont utilisés pour les lactames macrocycliques ?\nQuels symptômes indiquent une infection nécessitant des lactames ?\nComment évaluer l'efficacité des lactames macrocycliques ?\nQuels examens d'imagerie sont utiles ?",
"url": "https://questionsmedicales.fr/mesh/D047029?page=127#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Lactames macrocycliques",
"description": "Quels sont les symptômes d'une infection bactérienne ?\nLes lactames provoquent-ils des effets secondaires ?\nComment reconnaître une réaction allergique ?\nQuels signes d'infection nécessitent une attention médicale ?\nLes lactames macrocycliques affectent-ils le système digestif ?",
"url": "https://questionsmedicales.fr/mesh/D047029?page=127#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Lactames macrocycliques",
"description": "Comment prévenir les infections bactériennes ?\nLes lactames macrocycliques sont-ils utilisés en prophylaxie ?\nQuelles mesures d'hygiène sont recommandées ?\nLes vaccinations aident-elles contre les infections ?\nComment éviter la résistance aux antibiotiques ?",
"url": "https://questionsmedicales.fr/mesh/D047029?page=127#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Lactames macrocycliques",
"description": "Comment les lactames macrocycliques sont-ils administrés ?\nQuel est le mécanisme d'action des lactames ?\nCombien de temps dure un traitement typique ?\nQuels antibiotiques sont des lactames macrocycliques ?\nComment gérer les effets secondaires des lactames ?",
"url": "https://questionsmedicales.fr/mesh/D047029?page=127#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Lactames macrocycliques",
"description": "Quelles complications peuvent survenir avec les lactames ?\nComment gérer une surinfection ?\nLes lactames peuvent-ils causer des troubles rénaux ?\nQuels sont les signes d'une réaction sévère ?\nLes lactames macrocycliques peuvent-ils interagir avec d'autres médicaments ?",
"url": "https://questionsmedicales.fr/mesh/D047029?page=127#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Lactames macrocycliques",
"description": "Quels facteurs augmentent le risque d'infection ?\nLes antécédents d'allergies influencent-ils le traitement ?\nLe mode de vie affecte-t-il le risque d'infection ?\nLes personnes âgées sont-elles plus à risque ?\nLes voyages augmentent-ils le risque d'infections ?",
"url": "https://questionsmedicales.fr/mesh/D047029?page=127#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection bactérienne ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des cultures bactériennes et des tests de sensibilité."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour les lactames macrocycliques ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de sensibilité aux antibiotiques sont effectués pour évaluer l'efficacité."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection nécessitant des lactames ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, douleur, inflammation et signes d'infection localisée peuvent indiquer une infection."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité des lactames macrocycliques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par l'amélioration clinique et la réduction des cultures positives."
}
},
{
"@type": "Question",
"name": "Quels examens d'imagerie sont utiles ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des radiographies ou IRM peuvent être utilisées pour évaluer des infections profondes."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une infection bactérienne ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, frissons, douleur, rougeur et gonflement au site d'infection sont fréquents."
}
},
{
"@type": "Question",
"name": "Les lactames provoquent-ils des effets secondaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires comme des éruptions cutanées ou des troubles gastro-intestinaux peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une réaction allergique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des démangeaisons, un gonflement ou des difficultés respiratoires peuvent indiquer une allergie."
}
},
{
"@type": "Question",
"name": "Quels signes d'infection nécessitent une attention médicale ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une fièvre élevée persistante ou des douleurs intenses doivent être évaluées par un médecin."
}
},
{
"@type": "Question",
"name": "Les lactames macrocycliques affectent-ils le système digestif ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent causer des nausées, vomissements ou diarrhées chez certains patients."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections bactériennes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne hygiène, des vaccinations et un usage prudent des antibiotiques aident à prévenir."
}
},
{
"@type": "Question",
"name": "Les lactames macrocycliques sont-ils utilisés en prophylaxie ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être utilisés en prophylaxie pour prévenir des infections post-chirurgicales."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains régulièrement et éviter le contact avec des personnes malades sont essentiels."
}
},
{
"@type": "Question",
"name": "Les vaccinations aident-elles contre les infections ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations peuvent réduire le risque d'infections bactériennes spécifiques."
}
},
{
"@type": "Question",
"name": "Comment éviter la résistance aux antibiotiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser les antibiotiques uniquement lorsque nécessaire et suivre les prescriptions médicales."
}
},
{
"@type": "Question",
"name": "Comment les lactames macrocycliques sont-ils administrés ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent être administrés par voie intraveineuse ou orale, selon l'infection."
}
},
{
"@type": "Question",
"name": "Quel est le mécanisme d'action des lactames ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils inhibent la synthèse de la paroi cellulaire bactérienne, entraînant la mort des bactéries."
}
},
{
"@type": "Question",
"name": "Combien de temps dure un traitement typique ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée du traitement varie, mais elle est généralement de 7 à 14 jours selon l'infection."
}
},
{
"@type": "Question",
"name": "Quels antibiotiques sont des lactames macrocycliques ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des exemples incluent la méropénème et l'imipénème, utilisés pour des infections graves."
}
},
{
"@type": "Question",
"name": "Comment gérer les effets secondaires des lactames ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est important de signaler tout effet indésirable au médecin pour ajuster le traitement."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les lactames ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des réactions allergiques graves ou des infections secondaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment gérer une surinfection ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une évaluation médicale est nécessaire pour ajuster le traitement et cibler la nouvelle infection."
}
},
{
"@type": "Question",
"name": "Les lactames peuvent-ils causer des troubles rénaux ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains lactames peuvent affecter la fonction rénale, nécessitant une surveillance."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une réaction sévère ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des difficultés respiratoires ou un gonflement du visage nécessitent une urgence."
}
},
{
"@type": "Question",
"name": "Les lactames macrocycliques peuvent-ils interagir avec d'autres médicaments ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent interagir avec d'autres médicaments, il est donc important d'informer le médecin."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'infection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'immunodépression, le diabète et les interventions chirurgicales augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les antécédents d'allergies influencent-ils le traitement ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents d'allergies aux antibiotiques peuvent limiter les options de traitement."
}
},
{
"@type": "Question",
"name": "Le mode de vie affecte-t-il le risque d'infection ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un système immunitaire affaibli, les rendant plus vulnérables."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque d'infections ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages peuvent exposer à des agents pathogènes inconnus, augmentant le risque d'infection."
}
}
]
}
]
}
Fully aromatic helicenes are attractive building blocks for the construction of inherently chiral π-conjugated macrocyclic nanocarbons. These hitherto rare molecular architectures are envisaged to exh...
As previous studies reported, gadolinium deposits in globus pallidus (GP) and dentate nucleus (DN) after repeated administrations of gadolinium-based contrast agents (GBCAs) and a signal intensity (SI...
To identify whether quantitative susceptibility mapping (QSM) could measure a subtle increase in magnetic susceptibility in DN and GP in patients after repeated administrations of gadoteric acid meglu...
In this study, 50 patients with cerebral tumors who had received at least three injections of Gd-DOTA (GBCA group) and 50 individuals without a history of GBCA injections (non-GBCA group) were include...
The mean magnetic susceptibility of GP in GBCA group was 0.136 ±...
In comparison to the control group, the magnetic susceptibility of GP in the GBCA group was significantly higher and had a substantial positive association with the number of Gd-DOTA injections....
High-resolution structures are crucial for understanding the functional properties of nanomaterials. We applied single-particle cryo-electron microscopy (cryo-EM), a method traditionally used for stru...
Silica-based mesoporous materials have received growing attention in metal recovery from industrial processes, although, in general, the adsorption of metal ions by silanols is rather poor. Neverthele...
Cyclic peptides that modulate protein-protein interactions can be valuable therapeutic candidates if they can be delivered intact to their target proteins in cells. Here we systematically compare the ...
Isoindolinones, bearing both γ-lactam and aromatic rings, draw extensive interest in organic, pharmaceutical, and medicinal communities as they are important structural motifs in many natural products...
The Pharmacokinetic/Pharmacodynamic (PK/PD) relationship of antimicrobial drugs (AMD) for surgical prophylaxis has been poorly studied, hampering evidence-based decision making around AMD dosing and t...
Population pharmacokinetic studies of β-lactam antimicrobials in critically ill patients derive models that inform their dosing. In non-linear mixed-effects modelling, covariates are often used to imp...
We conducted a systematic review, searching MEDLINE, Embase, CENTRAL and Web of Science on 01 March 2023, including studies of critically ill adults receiving β-lactam antimicrobials who underwent blo...
Our search identified 151 studies with 6018 participants. Most studies reported observational cohorts (120 studies, 80%), with the majority conducted in high-income settings (136 studies, 90%). Of the...
Covariates are most commonly chosen based on biological plausibility, with patient characteristics and biomarkers the most frequently investigated. We developed an openly accessible database of report...
Managing drug-food interactions may help to achieve the optimal action and safety profile of β-lactam antibiotics....
We conducted a systematic review with meta-analyses in adherence to PRISMA guidelines for 32 β-lactams. We included 166 studies assessing the impact of food, beverages, antacids or mineral supplements...
Eighteen of 25 β-lactams for which data on food impact were available had clinically important interactions. We observed the highest negative influence of food (AUC or Cmax decreased by >40%) for ampi...
Factors such as physicochemical features of antibiotics, drug formulation, type of intervention, and patient's health state may influence interactions. Due to the poor actuality and diverse methodolog...
An all-fiber-optic system for rapid detection of antibiotic concentration, based on an optical enzyme biosensor with microfiber interferometer (MFI) and fiber gratings (FBGs) power variation, is propo...